Upsher-Smith Laboratories Names Rusty Field President

MAPLE GROVE, Minn., Aug. 24, 2015 /PRNewswire/ -- Upsher-Smith Laboratories, Inc. (Upsher-Smith) today announced that its Chief Commercial Officer, Rusty Field, has been named President of the company. Mr. Field brings with him more than three decades of sales, marketing, general management and strategic development experience, including seven years in the health sector. In this new role, Rusty will report directly to CEO Mark Evenstad and will be responsible for delivering revenue and profitability to meet the company's growth and future success objectives.

"During his tenure at Upsher-Smith, Rusty has proven himself to be an effective and innovative leader," said Mark Evenstad, Chief Executive Officer, Upsher-Smith. "I am confident that he has the skills, vision and values needed to fuel the company's growth, to deliver on current business objectives, and to lay the ground work for future success in a manner consistent with our company's vision, mission and values."

Rusty joined Upsher-Smith in 2014 after five years with United Healthcare, where he was responsible for distribution strategy and channel development. Before that, he spent twenty years with Ameriprise Financial, where he held senior executive sales, marketing and general management positions.

Rusty holds a B.A. in Economics from Williams College.

About Upsher-Smith

Upsher-Smith Laboratories, Inc., founded in 1919, is a growing, fully integrated pharmaceutical company dedicated to its mission of delivering high-value, high-quality therapies and solutions which measurably improve individuals' lives. As a family-owned pharmaceutical company, we are able to adapt and thrive in a dynamic healthcare environment. Our world is constantly evolving, and we are continually adapting to the ever-changing needs of patients, physicians, pharmacists, and healthcare organizations. Where there is a need, we will work to deliver solutions that simplify access to treatment, deliver better health outcomes, and enhance life. Upsher-Smith has a particular focus on developing therapies for people living with central nervous system (CNS) conditions, such as seizure disorders. For more information, visit www.upsher-smith.com.

 

Sponsored by GenScript

Accelerate Biologics, Gene and Cell Therapy Product Development partnering with GenScript ProBio

GenScript ProBio is the bio-pharmaceutical CDMO segment of the world’s leading biotech company GenScript, proactively providing end-to-end service from drug discovery to commercialization with professional solutions and efficient processes to accelerate drug development for customers.

Suggested Articles

City of Hope and Canadian biotech Biovaxys Technology reported positive animal data for their COVID vaccines that could offer alternatives to mRNA.

4D is adding a trio of executives to spearhead its work in heart, eye and lung diseases as it pushes programs into and through the clinic.

Janssen has sent off its mutation-specific non-small cell lung cancer drug amivantamab to the FDA.